Updated On: 13 October, 2020 09:40 AM IST | Washington | IANS
Johnsons Phase 3 trial started in September and it is one of six coronavirus vaccines being tested in the US, and one of four in the most advanced, Phase 3 stage

Johnson & Johnson. Pic/AFP
US pharmaceutical giant Johnson & Johnson announced that it has temporarily paused its Covid-19 vaccine trial after a participant became unwell.
"We have temporarily paused further dosing in all our Covid-19 vaccine candidate clinical trials, including the Phase 3 ENSEMBLE trial, due to an unexplained illness in a study participant," Xinhua news agency quoted the company as saying in a statement on Monday.